Zoetis Announced Earlier It Will Sell Its Medicated Feed Additive Portfolio To Phibro Animal Health For $350M
Portfolio Pulse from Charles Gross
Zoetis Inc. (ZTS) will sell its medicated feed additive portfolio to Phibro Animal Health Corporation (PAHC) for $350 million. The deal includes certain water soluble products and related assets, expected to close in the second half of 2024.
April 29, 2024 | 12:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Phibro Animal Health acquires Zoetis' medicated feed additive portfolio for $350 million, expanding its product range and potentially its market share.
Phibro's acquisition of Zoetis' medicated feed additive portfolio for $350 million is expected to positively impact its stock as it expands Phibro's product range and could potentially increase its market share in the animal health sector.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Zoetis Inc. is selling its medicated feed additive portfolio to Phibro Animal Health for $350 million, a move that could streamline its operations and focus on core areas.
The sale of the medicated feed additive portfolio by Zoetis to Phibro for $350 million is likely to be viewed positively by investors as it could streamline Zoetis' operations and allow it to focus on its core business areas, potentially improving profitability.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80